20.4 C
New York
Thursday, June 18, 2026

Tag: union

Agios Reports Second Quarter 2025 Financial Results and Provides Business Update

Agios Pharmaceuticals today announced financial results and updates for the second quarter ended June 30, 2025.

Consolidated unaudited interim report for the II quarter and first 6 months of 2025

A webinar on the presentation of the results (in Estonian only) will take place on 31 July at 13:00 (EEST), more information.

ANNOUNCEMENT OF A VOLUNTARY SHARE EXCHANGE OFFER MADE BY EURONEXT N.V. TO ACQUIRE THE ORDINARY REGISTERED SHARES OF HELLENIC EXCHANGES-ATHENS STOCK EXCHANGE S.A. IN...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE PROHIBITED BY, OR CONSTITUTE A VIOLATION OF, THE RELEVANT LAWS OF THAT JURISDICTION OR REQUIRE EURONEXT AND/OR ATHEX TO TAKE ANY FURTHER ACTION.

Immunocore to report second quarter 2025 financial results and host call on August 7, 2025

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.

Strong Q2 2025 financial results, PowerUp 2026 progressing according to plan

Q2 2025 RESULTS1
Net income group share at EUR 271 million, up 38.5% vs. Q2 2024

Tenaris Announces 2025 Second Quarter Results

The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Free Cash Flow, Net cash / debt and Operating working capital days. See exhibit I for more details on these alternative performance measures.

MINNESOTA TEAMSTERS UNANIMOUSLY AUTHORIZE STRIKE AT SYSCO

Local 120 Members Demand Fair Contract, Prepare to Strike MINNEAPOLIS, July 30, 2025 /PRNewswire/ -- Teamsters at Sysco Minnesota have voted unanimously to authorize a...

HANSEN ADKINS CARHAUL DRIVERS JOIN TEAMSTERS

Kansas City Drivers Choose Representation with Local 41, Set to Become Part of National Master Agreement   KANSAS CITY, Mo., July 30, 2025 /PRNewswire/ -- Carhaul...

Helpful information about PENNVEST program now available on PHFA podcast

PENNVEST program assists Pennsylvania homeowners with sewer and septic system costs HARRISBURG, Pa., July 30, 2025 /PRNewswire/ -- The latest episode of PHFA's "Close To Home"...

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis

– Nuvisertib (TP-3654), an oral investigational highly selective PIM-1 kinase inhibitor, is being evaluated in patients with relapsed or refractory myelofibrosis (MF) – MARLBOROUGH, Mass.,...

AMERICA’S TRUE SIGNING DAY GETS NATIONAL RECOGNITION IN MAJOR 250TH ANNIVERSARY EVENT

Ohio's Perry's Victory Memorial Hosts Declaration 250 Event PUT-IN-BAY, Ohio, July 30, 2025 /PRNewswire/ -- As the United States prepares to celebrate the 250th anniversary...

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

– New patent enhances market position in Europe

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsUnion